DOXORUBICINOL - A MORE POTENT CARDIOTOXIN THAN DOXORUBICIN

被引：0
作者：
OLSON, RD
BRENNER, DE
MUSHLIN, PS
BOERTH, RC
HANDE, KR
BOUCEK, RJ
机构：
[1] UNIV S ALABAMA,MOBILE,AL 36688
[2] UNIV WASHINGTON,SEATTLE,WA 98195
[3] VET ADM MED CTR,BOISE,ID
[4] VET ADM MED CTR,NASHVILLE,TN 37203
[5] VANDERBILT UNIV,NASHVILLE,TN 37240
来源：
PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH | 1985年 / 26卷 / MAR期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：227 / 227
页数：1
相关论文
共 50 条
  • [41] PHARMACOKINETICS OF DOXORUBICIN AND ITS METABOLITE DOXORUBICINOL IN RABBITS WITH INDUCED ACID AND ALKALINE URINE
    JOHANSEN, PB
    JENSEN, SE
    RASMUSSEN, SN
    DALMARK, M
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1984, 13 (01) : 5 - 8
  • [42] Population pharmacokinetics of doxorubicin and doxorubicinol in patients diagnosed with non-Hodgkin's lymphoma
    Samuel Perez-Blanco, Jonas
    Santos-Buelga, Dolores
    del Mar Fernandez de Gatta, Maria
    Maria Hernandez-Rivas, Jesus
    Martin, Alejandro
    Jose Garcia, Maria
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2016, 82 (06) : 1517 - 1527
  • [43] Direct quantitation of free, encapsulated, total doxorubicin and doxorubicinol in stabilized frozen human plasma to support a BE study of liposomal doxorubicin
    Ji, Yuhuan
    Zhang, Xueyuan
    Liu, Jinzhi
    Chen, Yu
    Meng, Min
    Li, ChunLei
    Wang, Laixin
    JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2020, 189
  • [44] Determination of doxorubicin and doxorubicinol in plasma of cancer patients by high-performance liquid chromatography
    de Bruijn, P
    Verweij, J
    Loos, WJ
    Kolker, HJ
    Planting, AST
    Nooter, K
    Stoter, G
    Sparreboom, A
    ANALYTICAL BIOCHEMISTRY, 1999, 266 (02) : 216 - 221
  • [45] DOXORUBICIN AND DOXORUBICINOL-INDUCED ALTERATIONS IN HUMAN POLYMORPHONUCLEAR LEUKOCYTE OXYGEN METABOLITE GENERATION
    NIELSON, CP
    BRENNER, D
    OLSON, RD
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 1986, 238 (01) : 19 - 25
  • [46] ACCELERATED DISAPPEARANCE OF DOXORUBICIN (DOX) AND DOXORUBICINOL (DOXOL) FROM PLASMA FOLLOWING PRIOR CHEMOTHERAPY
    TIPPING, S
    RIGGS, CE
    EGORIN, MJ
    WHITACRE, M
    VANECHO, DA
    AISNER, J
    BACHUR, NR
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1982, 23 (MAR): : 132 - 132
  • [47] Simultaneous analysis of cyclophosphamide, doxorubicin and doxorubicinol by liquid chromatography coupled to tandem mass spectrometry
    DiFrancesco, Robin
    Griggs, Jennifer J.
    Donnelly, Julie
    DiCenzo, Robert
    JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES, 2007, 852 (1-2): : 545 - 553
  • [48] Simultaneous liquid chromatographic determination of doxorubicin and its major metabolite doxorubicinol in parrot plasma
    Gilbert, CM
    McGeary, RP
    Filippich, LJ
    Norris, RLG
    Charles, BG
    JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES, 2005, 826 (1-2): : 273 - 276
  • [49] Population pharmacokinetic modelling of doxorubicin and doxorubicinol in children with cancer: is there a relationship with cardiac troponin profiles?
    Kuhan Kunarajah
    Stefanie Hennig
    Ross L. G. Norris
    Michael Lobb
    Bruce G. Charles
    Ross Pinkerton
    Andrew S. Moore
    Cancer Chemotherapy and Pharmacology, 2017, 80 : 15 - 25
  • [50] Carbonyl Reductase 1 Plays a Significant Role in Converting Doxorubicin to Cardiotoxic Doxorubicinol in Mouse Liver, but the Majority of the Doxorubicinol-Forming Activity Remains Unidentified
    Breysse, Daniel H.
    Boone, Ryan M.
    Long, Cameron M.
    Merrill, Miranda E.
    Schaupp, Christopher M.
    White, Collin C.
    Kavanagh, Terrance J.
    Schmidt, Edward E.
    Merrill, Gary F.
    DRUG METABOLISM AND DISPOSITION, 2020, 48 (03) : 187 - 197
12345